Mycophenolate mofetil and Transplant rejection - a phase IV clinical study of FDA data

Summary:

Transplant rejection is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Tacrolimus, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Transplant rejection when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Transplant rejection?

Transplant rejection (a transplant material is not worked) is found to be associated with 404 drugs and 735 conditions by eHealthMe. Check the latest studies of Transplant rejection.

On Jul, 26, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 3,520 people (3.78%) have Transplant rejection.

Could Mycophenolate mofetil cause Transplant rejection?

Among these 3,520 people:

How long have people been on Mycophenolate mofetil when they have Transplant rejection? *

Click here to view more results

What is the gender of people who have Transplant rejection when taking Mycophenolate mofetil? *

Click here to view

What is the age of people who have Transplant rejection when taking Mycophenolate mofetil? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Transplant rejection?

- Check whether Transplant rejection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Transplant rejection treatments and more:

Transplant rejection (12,413 reports)

How severe was Transplant rejection and when was it recovered:

Transplant rejection in Mycophenolate mofetil

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Transplant rejection and drugs with ingredients of mycophenolate mofetil (4,714 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transplant rejection:

Transplant rejection (404 drugs)

Browse all the conditions that are associated with Transplant rejection:

Transplant rejection (735 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.